Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates

Go back to Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates
(NASDAQ: CRBP) Delayed: 8.33 +0.07 (0.85%)
Previous Close $8.26    52 Week High $10.78 
Open $8.28    52 Week Low $1.01 
Day High $8.62    P/E N/A 
Day Low $8.26    EPS $0.00 
Volume 190,063